01 January 2005
Experiences with three different fi ber supplements in weight reduction
Grethe Støa Birketvedt, Mona Shimshi, Erling Thom, Jon FlorholmenMed Sci Monit 2005; 11(1): PI5-8 :: ID: 13883
Abstract
Background: Fiber supplements added to a caloric diet have additional effects on weight reduction in overweight subjects. The aim of this study was to compare the effect of various commercial fiber supplements (glucomannan, guar gum and alginate) on weight reduction in healthy overweight subjects. Material/Methods: One hundred and seventy six men and women were included to receive either active fi ber substance or placebo in randomized placebo-controlled studies. The fi ber supplements consisted of the viscous fi bers glucomannan (Chrombalance[sup]®[/sup]), glucomannan and guar gum (Appe-Trim[sup]®[/sup]) and glucomannan, guar gum and alginat (Glucosahl).Results: All fi ber supplements plus a balanced 1200 kcal diet induced signifi cantly weight reduction more than placebo and diet alone, during a fi ve week observation period. However, there were no signifi cant differences between the different fi bers in their ability to induce weight reduction, which was approximately 0.8 kg/week (3.8±0.9, 4.4±2.0, 4.1±0.6 in the Chrombalance, Appe-Trim[sup]®[/sup] and Glucosahl group, respectively).Conclusions: Glucomannan induced body weight reduction in healthy overweight subjects, whereas the addition of guar gum and alginate did not seem to cause additional loss of weight.
Keywords: Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Weight Loss - drug effects, Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Obesity - diet therapy, Plant Gums, Weight Loss - drug effects
1742 244
Editorial
01 November 2023 : Editorial
Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is DeclaredDOI: 10.12659/MSM.942960
Med Sci Monit 2023; 29:e942960
In Press
27 Nov 2023 : Clinical Research
Comparison of Outcomes from Emergency Admissions to a Major Trauma Center in Turkey of 1646 Elderly Patient...Med Sci Monit In Press; DOI: 10.12659/MSM.942916
27 Nov 2023 : Clinical Research
Evaluating Modified Ultrasound-Guided Serratus Anterior Plane Block for Enhanced Postoperative Recovery in ...Med Sci Monit In Press; DOI: 10.12659/MSM.942757
27 Nov 2023 : Clinical Research
Retrospective Study from a Single Center in Turkey to Compare Outcomes from Early Treatment, Elective Treat...Med Sci Monit In Press; DOI: 10.12659/MSM.942728
24 Nov 2023 : Clinical Research
Dermoscopic Evaluation of Actinic Changes in the Lips of Indigenous Children Living at High Altitude in Ecu...Med Sci Monit In Press; DOI: 10.12659/MSM.942554
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292